
Roselynne Ulm Cody
Examiner (ID: 6003, Phone: (571)272-8707 , Office: P/2917 )
| Most Active Art Unit | 2917 |
| Art Unit(s) | 2917, 2915 |
| Total Applications | 1541 |
| Issued Applications | 1504 |
| Pending Applications | 0 |
| Abandoned Applications | 37 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14306233
[patent_doc_number] => 20190142820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => DRUG FOR PREVENTING AND/OR TREATING DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 16/302097
[patent_app_country] => US
[patent_app_date] => 2017-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302097
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302097 | DRUG FOR PREVENTING AND/OR TREATING DEMENTIA | Apr 30, 2017 | Abandoned |
Array
(
[id] => 16572861
[patent_doc_number] => 10894774
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => Enhanced erythropoiesis and iron metabolism
[patent_app_type] => utility
[patent_app_number] => 15/498856
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 28229
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498856
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/498856 | Enhanced erythropoiesis and iron metabolism | Apr 26, 2017 | Issued |
Array
(
[id] => 11995456
[patent_doc_number] => 20170299612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'CARDIAC TROPONIN I DETECTION DURING PREGNANCY FOR CARDIOVASCULAR DISEASE IDENTIFICATION AND RISK ASSESSMENT'
[patent_app_type] => utility
[patent_app_number] => 15/487154
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18151
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487154
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487154 | CARDIAC TROPONIN I DETECTION DURING PREGNANCY FOR CARDIOVASCULAR DISEASE IDENTIFICATION AND RISK ASSESSMENT | Apr 12, 2017 | Abandoned |
Array
(
[id] => 11963918
[patent_doc_number] => 20170268069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy'
[patent_app_type] => utility
[patent_app_number] => 15/480126
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 26304
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480126
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480126 | Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy | Apr 4, 2017 | Issued |
Array
(
[id] => 14210479
[patent_doc_number] => 20190117624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/089872
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089872
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089872 | THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASES | Mar 27, 2017 | Abandoned |
Array
(
[id] => 12185345
[patent_doc_number] => 20180044281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/469359
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 24350
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469359
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/469359 | L-ornithine phenyl acetate and methods of making thereof | Mar 23, 2017 | Issued |
Array
(
[id] => 16755286
[patent_doc_number] => 10973812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Ataxia therapeutic compositions and methods
[patent_app_type] => utility
[patent_app_number] => 15/449257
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12521
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449257
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449257 | Ataxia therapeutic compositions and methods | Mar 2, 2017 | Issued |
Array
(
[id] => 11704500
[patent_doc_number] => 20170172999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'METHODS FOR TREATING VISCERAL FAT CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/446933
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7765
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15446933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/446933 | Methods for treating visceral fat conditions | Feb 28, 2017 | Issued |
Array
(
[id] => 14794585
[patent_doc_number] => 10400287
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Methods and materials for assessing homologous recombination deficiency
[patent_app_type] => utility
[patent_app_number] => 15/433249
[patent_app_country] => US
[patent_app_date] => 2017-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 42863
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 592
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15433249
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/433249 | Methods and materials for assessing homologous recombination deficiency | Feb 14, 2017 | Issued |
Array
(
[id] => 16459453
[patent_doc_number] => 10842780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Pharmaceutical composition for modified release
[patent_app_type] => utility
[patent_app_number] => 15/432854
[patent_app_country] => US
[patent_app_date] => 2017-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9623
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15432854
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/432854 | Pharmaceutical composition for modified release | Feb 13, 2017 | Issued |
Array
(
[id] => 14960547
[patent_doc_number] => 20190307751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => G PROTEIN-COUPLED RECEPTOR (GPCR) MODULATION BY IMIPRIDONES
[patent_app_type] => utility
[patent_app_number] => 16/073228
[patent_app_country] => US
[patent_app_date] => 2017-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073228
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073228 | G protein-coupled receptor (GPCR) modulation by imipridones | Jan 29, 2017 | Issued |
Array
(
[id] => 13314013
[patent_doc_number] => 20180208543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => NEW METHOD FOR SYNTHESIS OF FENFLURAMINE, AND NEW COMPOSITIONS COMPRISING IT
[patent_app_type] => utility
[patent_app_number] => 15/416053
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15416053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/416053 | NEW METHOD FOR SYNTHESIS OF FENFLURAMINE, AND NEW COMPOSITIONS COMPRISING IT | Jan 25, 2017 | Abandoned |
Array
(
[id] => 13645611
[patent_doc_number] => 09849104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-26
[patent_title] => Treatment of NASH with gemcabene
[patent_app_type] => utility
[patent_app_number] => 15/416911
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 39
[patent_no_of_words] => 20008
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15416911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/416911 | Treatment of NASH with gemcabene | Jan 25, 2017 | Issued |
Array
(
[id] => 11713514
[patent_doc_number] => 20170182013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS)'
[patent_app_type] => utility
[patent_app_number] => 15/398283
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21283
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398283
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398283 | Methods for treating irritable bowel syndrome (IBS) | Jan 3, 2017 | Issued |
Array
(
[id] => 13625329
[patent_doc_number] => 20180364216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => CHOROIDAL NEOVASCULARIZATION SUPPRESSOR OR DRUSEN FORMATION SUPPRESSOR, AND METHOD FOR ASSESSING OR SCREENING FOR SAME
[patent_app_type] => utility
[patent_app_number] => 16/063047
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063047 | Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same | Dec 15, 2016 | Issued |
Array
(
[id] => 11541664
[patent_doc_number] => 20170095488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 15/380824
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 47351
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380824
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380824 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | Dec 14, 2016 | Abandoned |
Array
(
[id] => 13049199
[patent_doc_number] => 10045976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Nicotine-containing liquid formulations and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/366678
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3698
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366678
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366678 | Nicotine-containing liquid formulations and uses thereof | Nov 30, 2016 | Issued |
Array
(
[id] => 11469537
[patent_doc_number] => 20170056320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'TRANSMUCOSAL DRUG DELIVERY SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 15/351650
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14832
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15351650
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/351650 | TRANSMUCOSAL DRUG DELIVERY SYSTEM | Nov 14, 2016 | Abandoned |
Array
(
[id] => 11469602
[patent_doc_number] => 20170056385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions'
[patent_app_type] => utility
[patent_app_number] => 15/349644
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14578
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349644
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349644 | Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions | Nov 10, 2016 | Abandoned |
Array
(
[id] => 12029496
[patent_doc_number] => 20170319596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'METHODS FOR IMPROVING QUALITY OF LIFE OR SEXUAL DOMAIN FUNCTION AND COMPOSITION USEFUL IN THE METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/348680
[patent_app_country] => US
[patent_app_date] => 2016-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17672
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15348680
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/348680 | METHODS FOR IMPROVING QUALITY OF LIFE OR SEXUAL DOMAIN FUNCTION AND COMPOSITION USEFUL IN THE METHODS | Nov 9, 2016 | Abandoned |